The largest database of trusted experimental protocols

7 protocols using anti cd56 pe

1

Evaluating NK Cell Cytotoxicity in CLL

Check if the same lab product or an alternative is used in the 5 most similar protocols
CLL patient PBMCs were treated with reovirus overnight and cocultured with EHEB, MEC-2 or autologous CLL targets (±rituximab or isotype control (R&D Systems)) at a 10:1 effector:target ratio. Cells were cultured for 1 h before the addition of anti-CD3 PerCP and anti-CD107a/b FITC (BD Biosciences), anti-CD56 PE (Miltenyi Biotec, San Diego, CA, USA) and 10 μg/ml brefeldin A (BioLegend, San Diego, CA, USA) for 4 h. Expression of CD107a/b on CD3CD56+ NK cells was determined.
+ Open protocol
+ Expand
2

Peripheral Lymphocyte Immunotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We quantified the CD 19 + lymphocytes (B cells), T CD3 + lymphocytes, T CD3 + CD4 + lymphocytes, T CD3 + CD8 + lymphocytes and CD56 + CD3- cells (NK cells). A polychromatic flow cytometry tube was used for peripheral lymphocyte immunotyping developed at the immunology laboratory of the National Medical Genetics Center (Zúñiga Rosales et al., 2020 ). The monoclonal antibodies conjugated with fluorochromes from MACS MiltenyiBiotec (Germany) included anti-CD45 APC-Vio770 (Clone 5B1), anti-CD19 PE-Vio700 (Clone LT19), anti-CD3 FITC (Clone BW264/56), anti-CD4 PerCP-Vio700 (Clone M−T466), anti-CD8 APC (Clone BW135/80), anti-CD56 PE (Clone REA196), (Fig. S1).
+ Open protocol
+ Expand
3

Phenotyping of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
After thawing PBMCs in PBS containing the endonuclease benzonase (Novagen/Merck Milipore Schwalbach, Germany), cells were directly stained in PBEA buffer (PBS, 0.5% BSA, 2 mM EDTA and 0.01% NaN3 ) for 30 min on 4°C. An overview of the B cell-, T cell- and NK cell/regulatory T cell (Treg)-phenotyping panels including fluorochromes is provided in Table S2. Cells were washed with PBEA buffer and fixed in PBS containing 1% formaldehyde. The following monoclonal antibodies were used after initial testing and titration: anti-CD3 Alexa-eFluor 780, anti-CD4 PE-Cy7, anti-CD19 Pe-Cy7, anti-CD27 APC, anti-CD28 FITC, and anti-CCR7 PE (eBioscience, SanDiego, USA), anti-CD4 PerCP-Cy5.5, anti-CD8+ PerCP-Cy5.5, anti-CD16 PerCP-Cy5.5, anti-CD20 FITC, anti-CD25 V450, anti-CD38 PerCP-Cy5.5, anti-CD45RA HV450, anti-CD69 FITC, anti-CD86 V450, anti-IFN-g APC, anti-IgD PE, anti-TNF-a FITC (Becton Dickenson GmbH, Heidelberg, Germany), anti-IL-2 PacificBlue (BioLegend,); anti-CD56 PE (Miltenyi, Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
4

NK Cell Cytotoxicity Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
NKCC was assessed using a modified version of the protocol described by Godoy-Ramirez et al. (13 (link)). Briefly, K562 target cells were cultured either alone or with NK cells at an effector:target (E:T) cell ratio of 10:1 for 4 h at 37°C in a humidified 5% CO2 atmosphere. After incubation, cells were pelleted and resuspended in PBS/1%BSA containing 0.3 µg anti-CD56 PE (Miltenyi Biotec). Following a 10-min incubation on ice, samples were washed in PBS and stained for 5 min with 125 nM of the dead cell stain sytox blue (Life Technologies) prior to flow cytometric analysis.
To measure NKCC, the number of lysed K562 target cells (defined as sytox blue positive) in a total population of 2000 was recorded. From here, the percentage of specific cell lysis was calculated as: (TL-SL/2000) × 100, where TL is the number of lysed target cells in NK-K562 co-culture samples and SL is the number of K562 cells that underwent lysis when cultured with media alone. To measure the target cell–NK cell conjugate formation rate, conjugates were defined as K562 cells exhibiting positive PE fluorescence and the number in a population of 2000 K562 cells was recorded.
+ Open protocol
+ Expand
5

NK Cell Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MALC obtained at day 10 of growth, were co-cultured with NK cells at ratio E:T 0.5:1 or 1:1 and treated or not with mAbs at 10 μl/ml during 4 h in presence of brefeldin A at 10 μl/mL (except of CD69 detection). Cells were then washed, fixed with 2% PFA during 4 min, washed and permeabilized with 1% saponin during 8 min. Cells were stained with anti-CD56-PE (Miltenyi Biotec), anti-CD3-PE/Cy7 (Beckman Coulter, Roissy, France), anti-CD69-PE-Cy5 (BD Biosciences), anti-perforin (PFN)-FITC (BD Biosciences), anti-IFN-γ-Alexa fluor 647 (BD Biosciences), anti-granzyme B-Alexa647 (BD Biosciences) antibodies during 30 min at 4°C in the dark. Cells were analyzed by flow cytometry with a LSRII flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
6

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry analysis, cells were washed with PBS containing 10% FBS and incubated for 30 minutes at 4°C for labeling with anti-CD3-FITC (BD Biosciences, clone OKT3), anti-CD56-PE (Miltenyi Biotec, clone MEM-188), anti-CD57-APC (Biolegend, clone NK-1), anti-CD16-BV421 (BD Biosciences, clone 3G8), anti-NKG2C-BV510 (BD Biosciences, clone 134591) and 7AAD. For each sample, 100.000 events were recorded using a FACS Canto II cytometer (BD Bioscience). Cell populations were analyzed using FlowJo v.X.0.7 (TreeStar Inc.). Viability of thawed CB-NK cells was quantified using the LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit (Invitrogen) following the manufacturer’s instructions.
+ Open protocol
+ Expand
7

Reovirus-Induced NK Cell Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
CLL patient PBMCs were treated with reovirus overnight and co-cultured with EHEB, MEC-2 or autologous CLL targets (± rituximab or isotype control (R&D)) at a 10:1 effector:target ratio. Cells were cultured for 1 hour prior to the addition of anti-CD3 PerCP and anti-CD107a/b FITC (BD Biosciences), anti-CD56 PE (Miltenyi Biotec, San Diego, CA, USA) and 10μg/ml Brefeldin A (Biolegend, San Diego, CA, USA) for 4 hours. Expression of CD107a/b on CD3CD56+ NK cells was determined.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!